Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Chinese Medical Journal
|
February 29, 2024
Driving effect of P16 methylation on telomerase reverse transcriptase-mediated immortalization and transformation of normal human fibroblasts
Xuehong Zhang, Paiyun Li, Ying Gan, et al.
Plos One
|
January 29, 2015
Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis
Nadine Nelson, Shengyan Xiang, Xiaohong Zhang, et al.
Nature Communications
|
December 6, 2018
GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors
Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
The Journal of Biological Chemistry
|
December 21, 2017
Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity
Jheng-Yu Wu, Shengyan Xiang, Mu Zhang, et al.
Cells
|
October 6, 2020
HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1
Niko Moses, Mu Zhang, Jheng-Yu Wu, et al.
Molecular Cancer Therapeutics
|
July 10, 2024
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function
Shengyan Xiang, Kendall C Craig, Xingju Luo, et al.
Frontiers in Bioscience (Elite Edition)
|
December 29, 2009
Bing De Ling, a Chinese herbal formula, inhibits cancer cells growth via p53
Yingtao Zhang, Huiqin Dong, Zhenyu Li, et al.
The Journal of Biological Chemistry
|
February 17, 2019
HDAC6 regulates DNA damage response via deacetylating MLH1
Mu Zhang, Chen Hu, Niko Moses, et al.
The Journal of Biological Chemistry
|
July 30, 2015
Histone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2
Rangasudhagar Radhakrishnan, Yixuan Li, Shengyan Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2016
Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells
Xiaojia Niu, Jianyun Zhao, Jun Ma, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Chinese Medical Journal
|
February 29, 2024
Driving effect of P16 methylation on telomerase reverse transcriptase-mediated immortalization and transformation of normal human fibroblasts
Xuehong Zhang, Paiyun Li, Ying Gan, et al.
Plos One
|
January 29, 2015
Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis
Nadine Nelson, Shengyan Xiang, Xiaohong Zhang, et al.
Nature Communications
|
December 6, 2018
GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors
Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang, et al.
The Journal of Biological Chemistry
|
December 21, 2017
Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity
Jheng-Yu Wu, Shengyan Xiang, Mu Zhang, et al.
Cells
|
October 6, 2020
HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1
Niko Moses, Mu Zhang, Jheng-Yu Wu, et al.
Molecular Cancer Therapeutics
|
July 10, 2024
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function
Shengyan Xiang, Kendall C Craig, Xingju Luo, et al.
Frontiers in Bioscience (Elite Edition)
|
December 29, 2009
Bing De Ling, a Chinese herbal formula, inhibits cancer cells growth via p53
Yingtao Zhang, Huiqin Dong, Zhenyu Li, et al.
The Journal of Biological Chemistry
|
February 17, 2019
HDAC6 regulates DNA damage response via deacetylating MLH1
Mu Zhang, Chen Hu, Niko Moses, et al.
The Journal of Biological Chemistry
|
July 30, 2015
Histone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2
Rangasudhagar Radhakrishnan, Yixuan Li, Shengyan Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2016
Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells
Xiaojia Niu, Jianyun Zhao, Jun Ma, et al.
Page
of 3